
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Validation of Functional Lumen Imaging Probe Panometry Esophageal Motility Classification Version 2.0: A Study of 805 Patients</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Validation of Functional Lumen Imaging Probe Panometry Esophageal Motility Classification Version 2.0: A Study of 805 Patients</strong></summary>
            <div>
                <ul><li>Journal: Neurogastroenterology &amp; Motility.</li><li>Publication Date: 22 October 2025.</li><li>Funding: R01 DK137775 (J.E.P. and D.A.C.) from Public Health service.</li><li>Study validates FLIP panometry v2.0 classification for esophageal motility.</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What is the negative predictive value of normal FLIP panometry for disorders of EGJ outflow?</li><li>2. What percentage of patients with non-spastic obstruction on FLIP panometry had a conclusive disorder of EGJ outflow on HRM?</li><li>3. What pressure threshold at 60 mL EGJ-DI differentiates disordered from diminished contractile response in FLIP v2.0?</li><li>4. What percentage of type III achalasia patients were classified as spastic obstruction on FLIP panometry v2.0?</li><li>5. What is the maximum hiatal hernia size allowed for inclusion in this study?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Introduction to FLIP Panometry</strong></summary>
            <div>
                <ul><li>FLIP panometry assesses esophageal motility.</li><li>Displays esophageal diameter topography + associated distensive pressure.</li><li>Evaluates EGJ opening mechanics + contractile response (CR) to distension.</li></ul>
                
        <details>
            <summary><strong>Advantages over HRM</strong></summary>
            <div>
                <ul><li>Performed during sedated endoscopy → ↑ patient tolerance.</li><li>Real-time motility interpretation.</li><li>Procedure + interpretation ≈ several minutes.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Evolution of FLIP Classification</strong></summary>
            <div>
                <ul><li>Initial FLIP v1.0 effective, comparable to HRM/CCv4.0.</li><li>Dallas Consensus introduced FLIP v2.0 → standardized protocol + refined classification.</li><li>Refinement mirrors iterative changes in Chicago Classification for HRM.</li></ul>
                
        <details>
            <summary><strong>Key Changes: v1.0 → v2.0</strong></summary>
            <div>
                <ul><li>EGJ opening criteria unchanged; &#x27;borderline&#x27; (v1.0) → &#x27;inconclusive&#x27; (v2.0).</li><li>Impaired/disordered CR (v1.0) subdivided into diminished vs. disordered CR.</li><li>Obstruction w/ weak CR reclassified into non-spastic + spastic subtypes.</li></ul>
                
        <details>
            <summary><strong>Contractile Response (CR) Pattern Changes</strong></summary>
            <div>
                <ul><li>v1.0: Impaired/Disordered CR.</li><li>v2.0: Diminished CR (FLIP pressure ≤ 40 mmHg @ 60mL EGJ-DI); Disordered CR (FLIP pressure &gt; 40 mmHg @ 60mL EGJ-DI).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Motility Classification Changes</strong></summary>
            <div>
                <ul><li>v1.0: Obstruction w/ weak CR.</li><li>v2.0: Non-spastic obstruction; Spastic obstruction.</li><li>Aimed to improve achalasia phenotyping + align w/ HRM.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Methods: Study Design &amp; Protocols</strong></summary>
            <div>
                <ul><li>Multicenter study: 805 adult patients (18–91 yrs).</li><li>Completed both FLIP + HRM @ two tertiary esophageal centers.</li><li>Primary analysis: 704 patients w/ conclusive CCv4.0 diagnoses.</li></ul>
                
        <details>
            <summary><strong>Subject Inclusion/Exclusion</strong></summary>
            <div>
                <ul><li>Inclusion: Adult patients presenting for esophageal symptom evaluation, underwent FLIP during sedated EGD w/ corresponding HRM.</li><li>Exclusion: Technically limited FLIP/HRM; prior foregut surgery/pneumatic dilation; esophageal mechanical obstruction (stricture, EoE, severe reflux esophagitis [LA grade C/D], or hiatal hernia &gt; 3 cm).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Study Protocol &amp; Analysis</strong></summary>
            <div>
                <ul><li>Performed during sedated EGD (moderate sedation/propofol).</li><li>16-cm FLIP catheter (EndoFLIP EF-322N) per Dallas consensus.</li><li>Catheter positioned w/ distal 1–3 impedance sensors beyond EGJ.</li></ul>
                
        <details>
            <summary><strong>Distension Protocol</strong></summary>
            <div>
                <ul><li>Bag filled stepwise 10-mL increments from 40 mL to 70 mL.</li><li>Each distension volume maintained for 30–60 s.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Data Analysis</strong></summary>
            <div>
                <ul><li>Post-endoscopy using customized program (wklytics.com/nmgi).</li><li>Raters blinded to clinical details (HRM, TBE).</li><li>Interpretation used FLIP Panometry motility classification v1.0 + v2.0 criteria.</li></ul>
                
        <details>
            <summary><strong>Assessment Parameters</strong></summary>
            <div>
                <ul><li>Contractile response (CR) pattern: evaluated during 50–70 mL fill volumes.</li><li>EGJ opening classification: based on EGJ-distensibility index (EGJ-DI) @ 60 mL + maximum EGJ diameter @ 60–70 mL.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry v2.0 Classification Criteria</strong></summary>
            <div>
                <ul><li>Defines CR patterns, EGJ opening, + motility classifications.</li></ul>
                
        <details>
            <summary><strong>Contractile Response (CR) Patterns</strong></summary>
            <div>
                <ul><li>Normal CR: &gt;1 distinct antegrade contractions (≥6-cm axial length) w/ FLIP pressure rise &gt;10 mmHg.</li><li>Diminished CR: Contractility present, not normal/spastic; FLIP pressure (w/ 60mL EGJ-DI) ≤40 mmHg.</li><li>Disordered CR: Contractility present, not normal/spastic; FLIP pressure (w/ 60mL EGJ-DI) &gt;40 mmHg.</li><li>Absent CR: No contractile activity in esophageal body.</li><li>Spastic CR: Presence of sustained occluding contractions OR sustained lower esophageal sphincter contractions.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>EGJ Opening Classifications</strong></summary>
            <div>
                <ul><li>Reduced EGJ opening: EGJ-DI &lt;2.0 mm²/mmHg AND Maximum EGJ diameter &lt;12 mm.</li><li>Inconclusive EGJ opening: EGJ-DI &lt;2.0 mm²/mmHg OR Maximum EGJ diameter &lt;16 mm (not meeting reduced criteria).</li><li>Normal EGJ opening: EGJ-DI ≥2.0 mm²/mmHg AND Maximum EGJ diameter ≥16 mm.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Motility Classifications (v2.0)</strong></summary>
            <div>
                <ul><li>Normal motility: Normal EGJ opening + Normal CR.</li><li>Hypocontractility: Normal EGJ opening + Absent/Diminished CR.</li><li>Possible spasm: Normal EGJ opening + Spastic/Disordered CR.</li><li>Possible obstruction: Inconclusive EGJ opening + Any CR (recommended to specify CR pattern).</li><li>Spastic obstruction: Reduced EGJ opening + Spastic/Disordered CR.</li><li>Non-spastic obstruction: Reduced EGJ opening + Absent/Diminished CR.</li><li>Obstruction w/ normal contractility: Reduced EGJ opening + Normal CR (none observed in study).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>HRM Protocol &amp; Analysis</strong></summary>
            <div>
                <ul><li>Performed after ≥6-h fast.</li><li>4.2-mm solid-state assembly w/ 36 circumferential pressure sensors.</li><li>Transnasal placement, positioned hypopharynx to stomach.</li></ul>
                
        <details>
            <summary><strong>HRM Protocol</strong></summary>
            <div>
                <ul><li>2-min baseline recording.</li><li>CCv4.0 protocol: 10x 5-mL liquid swallows (supine), then 5x 5-mL liquid swallows (upright).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Data Analysis</strong></summary>
            <div>
                <ul><li>Analyzed per CCv4.0 criteria; investigators blinded.</li><li>Abnormal IRP: &gt;15 mmHg (supine swallows) OR &gt;12 mmHg (upright swallows).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Role of Timed Barium Esophagram (TBE)</strong></summary>
            <div>
                <ul><li>Applied for inconclusive HRM (EGJOO/absent contractility w/ IRP @ upper limit of normal).</li><li>Upright position: 200 mL low-density barium sulfate; anteroposterior images @ 1, 2, 5 min.</li><li>12.5 mm barium tablet administered if no significant retention after 5 min.</li></ul>
                
        <details>
            <summary><strong>TBE Interpretation</strong></summary>
            <div>
                <ul><li>Abnormal TBE: Barium column height &gt;5 cm @ 5 min OR &gt;5 cm @ 1 min + tablet impaction → conclusive disorders of EGJ outflow.</li><li>Normal TBE: Normal EGJ outflow.</li><li>Missing/Inconclusive TBE: Excluded from primary analysis due to clinical uncertainty.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Statistical Analysis</strong></summary>
            <div>
                <ul><li>Results: mean (SD) or median (IQR).</li><li>Group comparisons: χ² test (categorical); ANOVA/t-tests or Kruskal–Wallis/Mann–Whitney U test (continuous).</li><li>Statistical significance: two-tailed p-value &lt;0.05.</li><li>Software: R version 4.4.2 (tidyverse, ggplot2 packages).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Results: Cohort Characteristics</strong></summary>
            <div>
                <ul><li>Total cohort: 805 patients.</li><li>Mean age: 55 (17) years; 62% female.</li><li>Dysphagia: most common indication (75%).</li></ul>
                
        <details>
            <summary><strong>Study Sites</strong></summary>
            <div>
                <ul><li>Site 1: 607 subjects.</li><li>Site 2: 198 subjects.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Interval</strong></summary>
            <div>
                <ul><li>66% underwent FLIP + HRM on same day.</li><li>Remainder: median interval 1.5 (0.6–3.2) months between studies.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>HRM Classifications (Total Cohort)</strong></summary>
            <div>
                <ul><li>Normal esophageal motility: 264 (33%).</li><li>Achalasia (subtypes I, II, or III): 241 (30%).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Inconclusive HRM/CCv4.0 Diagnoses</strong></summary>
            <div>
                <ul><li>101 patients (mean age 61 (14) yrs; 66% female).</li><li>Most common reason: inconclusive HRM (typically EGJOO) + absence of TBE (88 participants).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Adverse Events</strong></summary>
            <div>
                <ul><li>No adverse events during FLIP studies.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Cohort Characteristics by FLIP v2.0 Classification</strong></summary>
            <div>
                <ul><li>Dysphagia: most common indication across all FLIP v2.0 classifications.</li><li>Reflux: more common in normal, hypocontractility, + possible spasm classifications.</li><li>Mild esophagitis (LA Grade A/B): more common in normal + hypocontractility classifications.</li><li>Hiatal hernia (on HRM; ≤3 cm): least frequent in non-spastic obstruction.</li></ul>
                
        <details>
            <summary><strong>FLIP v2.0 Classification Distribution (Total Cohort)</strong></summary>
            <div>
                <ul><li>Normal motility: 19%.</li><li>Hypocontractility: 11%.</li><li>Non-spastic obstruction: 23%.</li><li>Spastic obstruction: 11%.</li><li>Possible spasm: 7.2%.</li><li>Possible obstruction: 28%.</li><li>Obstruction w/ normal contractility: 0% (no patients classified).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Results: FLIP Panometry Evaluation (Primary Analysis, n=704)</strong></summary>
            <div>
                <ul><li>Primary analysis focused on 704 participants w/ conclusive HRM/CCv4.0 diagnosis.</li></ul>
                
        <details>
            <summary><strong>EGJ Opening Classifications</strong></summary>
            <div>
                <ul><li>Normal EGJ opening: 266 (38%) patients.</li><li>Inconclusive EGJ opening: 199 (28%) patients.</li><li>Reduced EGJ opening: 239 (34%) patients.</li></ul>
                
        <details>
            <summary><strong>Correlation w/ HRM/CCv4.0</strong></summary>
            <div>
                <ul><li>Normal EGJ opening: 98.5% had normal EGJ outflow per HRM/CCv4.0.</li><li>Reduced EGJ opening: 81.6% had a disorder of EGJ outflow.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Contractile Response (CR) Patterns</strong></summary>
            <div>
                <ul><li>Normal CR: 158 (22.4%) participants.</li><li>Diminished CR: 85 (12.1%) participants.</li><li>Absent CR: 252 (35.8%) participants.</li><li>Disordered CR: 113 (16.1%) participants.</li><li>Spastic CR: 96 (13.6%) participants.</li></ul>
                
        <details>
            <summary><strong>Correlation w/ Achalasia/EGJOO</strong></summary>
            <div>
                <ul><li>Only 1 patient w/ normal CR had achalasia (type III).</li><li>3 patients w/ normal CR had conclusive EGJOO.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Results: FLIP Panometry v2.0 Motility Classifications (Primary Analysis, n=704)</strong></summary>
            <div>
                <ul><li>FLIP v2.0 classifications frequently paralleled HRM/CCv4.0 diagnoses.</li></ul>
                
        <details>
            <summary><strong>Normal Motility (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>137 patients classified as normal by FLIP panometry.</li><li>81% had normal motility per CCv4.0.</li><li>12% had IEM per CCv4.0.</li></ul>
                
        <details>
            <summary><strong>Predictive Value</strong></summary>
            <div>
                <ul><li>99% negative predictive value for disorders of EGJ outflow.</li><li>0 patients w/ achalasia on HRM.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Hypocontractility (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>78 patients classified as hypocontractility.</li><li>72% had absent contractility or IEM.</li><li>27% had normal motility.</li><li>1 patient had type II achalasia (symptoms minimal, TBE normal clearance).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Non-Spastic Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>163 patients classified as non-spastic obstruction.</li><li>77% had type I (31%) or II (47%) achalasia.</li><li>8.0% had type III achalasia.</li><li>5.5% had conclusive EGJOO.</li></ul>
                
        <details>
            <summary><strong>Predictive Value</strong></summary>
            <div>
                <ul><li>91% had a disorder of EGJ outflow by HRM/CCv4.0.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Spastic Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>76 patients classified as spastic obstruction.</li><li>32% had type I (2.6%) or II (29%) achalasia.</li><li>21% had type III achalasia.</li></ul>
                
        <details>
            <summary><strong>Type III Achalasia Correlation</strong></summary>
            <div>
                <ul><li>Among 37 patients w/ type III achalasia:</li><li>43% classified as spastic obstruction by FLIP v2.0.</li><li>35% classified as non-spastic obstruction.</li><li>22% classified as possible obstruction.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Possible Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>199 patients classified as possible obstruction.</li><li>38% had normal motility.</li><li>26% had type I/II achalasia.</li><li>16% had IEM.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Results: Comparing FLIP Panometry v1.0 and v2.0</strong></summary>
            <div>
                <ul><li>v2.0 refinements aimed to improve alignment w/ HRM findings.</li></ul>
                
        <details>
            <summary><strong>Reclassification of &#x27;Obstruction w/ Weak CR&#x27; (v1.0)</strong></summary>
            <div>
                <ul><li>v1.0 &#x27;Obstruction w/ weak CR&#x27; patients (26% type I, 43% type II, 10% type III achalasia) were reclassified in v2.0.</li><li>Reclassified as:</li><li>Non-spastic obstruction (v2.0): 31% type I, 47% type II, 8.0% type III achalasia.</li><li>Spastic obstruction (v2.0): 3% type I, 29% type II, 21% type III achalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Reclassification of &#x27;Weak&#x27; (v1.0)</strong></summary>
            <div>
                <ul><li>v1.0 &#x27;Weak&#x27; classification (32% absent contractility, 27% IEM, 2.7% hypercontractile esophagus) reclassified in v2.0.</li><li>Reclassified as:</li><li>Hypocontractility (v2.0): 44% absent contractility, 28% IEM, 0% hypercontractile/spasm.</li><li>Possible spasm (v2.0): 2.0% absent contractility, 24% IEM, 7.8% hypercontractile esophagus, 0% spasm.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Reclassification of &#x27;Spastic Reactive&#x27; (v1.0)</strong></summary>
            <div>
                <ul><li>v1.0 &#x27;Spastic reactive&#x27; classification (13% type III achalasia) reclassified in v2.0.</li><li>Reclassified as:</li><li>Spastic obstruction (v2.0): 21% of type III achalasia.</li><li>Possible obstruction (v2.0): 4.0% of type III achalasia.</li><li>Possible spasm (v2.0): 0% type III achalasia.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Discussion: Key Findings &amp; Clinical Implications</strong></summary>
            <div>
                <ul><li>FLIP panometry v2.0 effectively categorizes esophageal motility.</li><li>Frequently aligns w/ HRM + CCv4.0.</li><li>Supports FLIP panometry as effective for diagnosing esophageal motility disorders.</li></ul>
                
        <details>
            <summary><strong>Normal Motility (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>Associated w/ normal motility or IEM on HRM in 93% (127/137) patients.</li><li>High negative predictive value (99%) for disorders of EGJ outflow (0 achalasia cases).</li><li>Suggests FLIP can rule out achalasia; may guide management away from HRM if assessed during index endoscopy.</li></ul>
                
        <details>
            <summary><strong>Alignment w/ Healthy Volunteers</strong></summary>
            <div>
                <ul><li>Proportion of DES (1%–14%) + IEM (7%–17%) in healthy volunteers on HRM aligns w/ findings in normal FLIP v2.0.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Non-Spastic Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>Strongly associated w/ achalasia or conclusive EGJOO.</li><li>Positive predictive value: 91%.</li><li>77% were non-spastic (type I or II) achalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Differentiation of Impaired/Disordered CR (IDCR)</strong></summary>
            <div>
                <ul><li>Major v2.0 update: IDCR (v1.0) → diminished CR or disordered CR.</li><li>Distinction based on 60 mL FLIP pressure measurements.</li><li>Pressure threshold: 40 mmHg @ 60-mL EGJ-DI.</li></ul>
                
        <details>
            <summary><strong>Improved Achalasia Subtyping</strong></summary>
            <div>
                <ul><li>Non-spastic obstruction (v2.0, includes diminished + absent CR): 77% non-spastic (type I/II) achalasia (vs. 69% w/ v1.0 &#x27;obstruction w/ weak CR&#x27;).</li><li>Spastic obstruction (v2.0, includes disordered + spastic CR): encompassed nearly half (16/37) of type III achalasia patients (21% of spastic obstruction cases).</li><li>Also included 22 patients (29%) w/ type II achalasia → suggests identifiable spastic variant of type II achalasia.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Enhanced Identification of Hypocontractile Disorders</strong></summary>
            <div>
                <ul><li>72% of hypocontractility (FLIP v2.0) had IEM or absent contractility on HRM/CCv4.0.</li><li>↑ from 59% using FLIP v1.0 &#x27;weak motility&#x27; classification.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>&#x27;Possible Spasm&#x27; Classification (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>Introduced to distinguish primary esophageal spasm from hypocontractile disorders.</li><li>Only 8% of &#x27;possible spasm&#x27; patients had hypercontractile esophagus or DES per HRM/CCv4.0.</li><li>65% had normal HRM → suggests impaired secondary peristalsis, not spastic variant w/ normal HRM.</li><li>Area requiring further refinement + validation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Strengths</strong></summary>
            <div>
                <ul><li>Large patient cohort w/ comprehensive esophageal evaluations.</li><li>Application of HRM + CCv4.0.</li><li>Cohort distinct from initial FLIP v1.0 study.</li><li>Multicenter design → enhances generalizability.</li><li>Higher prevalence of achalasia (referral centers) is a strength, as achalasia identification is clinically significant.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Limitations</strong></summary>
            <div>
                <ul><li>Absence of a definitive gold standard for diagnosis (key challenge in esophageal motility research).</li><li>Inconclusive/discordant diagnoses still occur despite state-of-the-art methods.</li><li>FLIP goal ≠ replicate HRM; methods assess distinct physiological processes (HRM: primary peristalsis; FLIP: secondary peristalsis).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Conclusion</strong></summary>
            <div>
                <ul><li>FLIP panometry v2.0 accurately identified esophageal motility disorders.</li><li>Should be interpreted w/ endoscopic + clinical data, similar to HRM.</li><li>Potential to expedite diagnosis + inform immediate endoscopic interventions (reinspection, dilation) or guide further testing.</li><li>Complements HRM; may serve as viable alternative in select cases.</li><li>Future studies: broader populations, longitudinal outcomes, unique subgroups.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
